These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29277234)

  • 1. Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):42. PubMed ID: 29277234
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction in Article by Vaglimi et al. "2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease Developed in Collaboration with EACTS", Rev Esp Cardiol. 2018;71:42.e1-e58.
    Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):508. PubMed ID: 29655767
    [No Abstract]   [Full Text] [Related]  

  • 3. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: What is new?].
    Öngen Z
    Turk Kardiyol Dern Ars; 2018 Jan; 46(1):1-6. PubMed ID: 29339684
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to: 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
    Eur Heart J; 2018 Jun; 39(22):2089. PubMed ID: 29087454
    [No Abstract]   [Full Text] [Related]  

  • 5. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Peticevic M; Roffi M; Steg PG; Windecker S; Zamorano JL
    Kardiol Pol; 2017; 75(12):1217-1299. PubMed ID: 29251754
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.
    ; Jiménez Navarro M; Avanzas P; Valencia F; Ballesteros S; Ruiz-Nodar JM; Ferreiro JL; Tello Montoliu A; Marín F; ; Pérez de Prado A; Romero Moreno M; Bravo MS; Ruiz Ortiz M; Escobar C; Roldán I; Vivas Balcones D; ; San Román A; Alfonso F; Evangelista A; Ferreira-González I; Jiménez Navarro M; Marín F; Pérez de Isla L; Rodríguez Padial L; Sánchez Fernández PL; Sionis A; Vázquez García R
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):6-12. PubMed ID: 29277237
    [No Abstract]   [Full Text] [Related]  

  • 7. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Kolh P; Windecker S; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Sousa Uva M; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A; ; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol Ç; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; ; Sousa Uva M; Achenbach S; Pepper J; Anyanwu A; Badimon L; Bauersachs J; Baumbach A; Beygui F; Bonaros N; De Carlo M; Deaton C; Dobrev D; Dunning J; Eeckhout E; Gielen S; Hasdai D; Kirchhof P; Luckraz H; Mahrholdt H; Montalescot G; Paparella D; Rastan AJ; Sanmartin M; Sergeant P; Silber S; Tamargo J; ten Berg J; Thiele H; van Geuns RJ; Wagner HO; Wassmann S; Wendler O; Zamorano JL; ;
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):517-92. PubMed ID: 25173601
    [No Abstract]   [Full Text] [Related]  

  • 8. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    ; Windecker S; Kolh P; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Sousa Uva M; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A
    Eur Heart J; 2014 Oct; 35(37):2541-619. PubMed ID: 25173339
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction to: Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation; 2016 Sep; 134(10):e195-7. PubMed ID: 27601567
    [No Abstract]   [Full Text] [Related]  

  • 10. Correction in the Article by Kirchhof et al. "2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS". Rev Esp Cardiol. 2017;70:50.e1-e84.
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):1031. PubMed ID: 28867171
    [No Abstract]   [Full Text] [Related]  

  • 11. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual antiplatelet therapy use by Canadian cardiac surgeons.
    Yanagawa B; Ruel M; Bonneau C; Lee MM; Chung J; Al Shouli S; Fagan A; Al Khalifa A; White CW; Yamashita MH; Currie ME; Teoh H; Mewhort HE; Verma S
    J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1548-54.e3. PubMed ID: 26395051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.
    Nocerino AG; Achenbach S; Taylor AJ
    Am J Cardiol; 2013 Nov; 112(10):1576-9. PubMed ID: 24035160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative antiplatelet management in patients with coronary artery stenting.
    Tandar A; Velagapudi KN; Wilson BD; Boden WE
    Hosp Pract (1995); 2012 Apr; 40(2):118-30. PubMed ID: 22615086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].
    Nef H; Renker M; Hamm CW; ;
    Herz; 2014 Dec; 39(8):913-8. PubMed ID: 25406330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
    Eur Heart J; 2018 Apr; 39(13):1109. PubMed ID: 28369313
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Fujisue K; Sugiyama S; Ono T; Matsuzawa Y; Akiyama E; Sugamura K; Matsubara J; Kurokawa H; Kaikita K; Iwashita S; Sumida H; Hokimoto S; Oniki K; Nakagawa K; Matsui K; Ogawa H
    Circ Cardiovasc Interv; 2013 Aug; 6(4):452-9. PubMed ID: 23922147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESC/EACTS guidelines on myocardial revascularization post-SYNTAX.
    Mohr FW; Davierwala PM
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):511-3. PubMed ID: 25193954
    [No Abstract]   [Full Text] [Related]  

  • 19. ESC/EACTS myocardial revascularization guidelines 2014.
    Kolh P; Windecker S
    Eur Heart J; 2014 Dec; 35(46):3235-6. PubMed ID: 25482397
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study.
    Gajos G; Rostoff P; Undas A; Piwowarska W
    J Am Coll Cardiol; 2010 Apr; 55(16):1671-8. PubMed ID: 20394870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.